Cargando…

TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice

Non-alcoholic fatty liver disease (NAFLD) shows an increasing prevalence and is associated with the development of liver fibrosis and cirrhosis as the major risk factors of liver-related mortality in this disease. The therapeutic possibilities are limited and restricted to life style intervention, s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wandrer, Franziska, Liebig, Stephanie, Marhenke, Silke, Vogel, Arndt, John, Katharina, Manns, Michael P., Teufel, Andreas, Itzel, Timo, Longerich, Thomas, Maier, Olaf, Fischer, Roman, Kontermann, Roland E., Pfizenmaier, Klaus, Schulze-Osthoff, Klaus, Bantel, Heike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109108/ https://www.ncbi.nlm.nih.gov/pubmed/32235829 http://dx.doi.org/10.1038/s41419-020-2411-6

Ejemplares similares

Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness
por: Liebig, Stephanie, et al.
Publicado: (2019)

BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatment
por: Busche, Stephanie, et al.
Publicado: (2021)

Cell death in sepsis: a matter of how, when, and where
por: Bantel, Heike, et al.
Publicado: (2009)

Mechanisms of Cell Death in Acute Liver Failure
por: Bantel, Heike, et al.
Publicado: (2012)

Autophagy alleviates amiodarone-induced hepatotoxicity
por: Wandrer, Franziska, et al.
Publicado: (2020)

Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
por: Fischer, Roman, et al.
Publicado: (2020)

The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation
por: Richter, Fabian, et al.
Publicado: (2021)

Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity
por: Richter, Fabian, et al.
Publicado: (2013)

Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitis
por: John, Katharina, et al.
Publicado: (2017)

Biopsy-Controlled Liver Fibrosis Staging Using the Enhanced Liver Fibrosis (ELF) Score Compared to Transient Elastography
por: Wahl, Kristin, et al.
Publicado: (2012)

Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4
por: John, Katharina, et al.
Publicado: (2022)

Antitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion Protein
por: Marini, Irene, et al.
Publicado: (2017)

α-Toxin is a mediator of Staphylococcus aureus–induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling
por: Bantel, Heike, et al.
Publicado: (2001)

A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell Death
por: Fischer, Roman, et al.
Publicado: (2011)

A Novel Anti-Kv10.1 Nanobody Fused to Single-Chain TRAIL Enhances Apoptosis Induction in Cancer Cells
por: Hartung, Franziska, et al.
Publicado: (2020)

Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity
por: Siegemund, M, et al.
Publicado: (2012)

Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans
por: Fellermeier-Kopf, Sina, et al.
Publicado: (2018)

p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury Model
por: Buitrago-Molina, Laura Elisa, et al.
Publicado: (2021)

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018)

Increased plasma levels of CK-18 as potential cell death biomarker in patients with HELLP syndrome
por: John, K, et al.
Publicado: (2013)

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
por: Bernhardt, Philipp, et al.
Publicado: (2018)

Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD
por: Gonzalez, Concepcion, et al.
Publicado: (2013)

Parenteral Nutrition Associated Hepatic Steatosis and NAFLD Intersect at AMPK
por: Guthrie, Gregory
Publicado: (2022)

IgG-single-chain TRAIL fusion proteins for tumour therapy
por: Siegemund, Martin, et al.
Publicado: (2018)

Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion Protein
por: Padutsch, Tanja, et al.
Publicado: (2019)

Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice
por: Kälble, Florian, et al.
Publicado: (2016)

Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis
por: Taubert, Richard, et al.
Publicado: (2018)

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
por: Fischer, Roman, et al.
Publicado: (2017)

Steatosis Grade is the Most Important Risk Factor for Development of Endothelial Dysfunction in NAFLD
por: Sapmaz, Ferdane, et al.
Publicado: (2016)

Selenoneine Ameliorates Hepatocellular Injury and Hepatic Steatosis in a Mouse Model of NAFLD
por: Miyata, Masaaki, et al.
Publicado: (2020)

Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway
por: Tong, Junlu, et al.
Publicado: (2022)

Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis
por: Fiedler, Timon, et al.
Publicado: (2023)

A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD
por: Ashworth, William B., et al.
Publicado: (2016)

The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis
por: Sans, Arnaud, et al.
Publicado: (2019)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD
por: Oh, Sechang, et al.
Publicado: (2021)

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
por: Segura-Azuara, Nancy de los Ángeles, et al.
Publicado: (2022)

Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD
por: Hu, Zhengyu, et al.
Publicado: (2022)

Acupuncture improved hepatic steatosis in HFD-induced NAFLD rats by regulating intestinal microbiota
por: Wang, Haiying, et al.
Publicado: (2023)

EGFR-Targeted TRAIL and a Smac Mimetic Synergize to Overcome Apoptosis Resistance in KRAS Mutant Colorectal Cancer Cells
por: Möller, Yvonne, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3s90ie6pvqf7sdvle73eb4ucop